CN1219933A - 新的噁唑烷衍生物、其制备方法和含这些化合物的药物制剂 - Google Patents

新的噁唑烷衍生物、其制备方法和含这些化合物的药物制剂 Download PDF

Info

Publication number
CN1219933A
CN1219933A CN97195072A CN97195072A CN1219933A CN 1219933 A CN1219933 A CN 1219933A CN 97195072 A CN97195072 A CN 97195072A CN 97195072 A CN97195072 A CN 97195072A CN 1219933 A CN1219933 A CN 1219933A
Authority
CN
China
Prior art keywords
hydrogen atom
oxo
octahydro
group
benzoxazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN97195072A
Other languages
English (en)
Chinese (zh)
Inventor
C·特萨克拉基迪斯
L·多尔格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19612827A external-priority patent/DE19612827A1/de
Priority claimed from DE1996154479 external-priority patent/DE19654479A1/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of CN1219933A publication Critical patent/CN1219933A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN97195072A 1996-03-30 1997-03-26 新的噁唑烷衍生物、其制备方法和含这些化合物的药物制剂 Pending CN1219933A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19612827A DE19612827A1 (de) 1996-03-30 1996-03-30 Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19612827.7 1996-12-27
DE1996154479 DE19654479A1 (de) 1996-12-27 1996-12-27 Neue Oxazolidinderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19654479.3 1996-12-27

Publications (1)

Publication Number Publication Date
CN1219933A true CN1219933A (zh) 1999-06-16

Family

ID=26024325

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97195072A Pending CN1219933A (zh) 1996-03-30 1997-03-26 新的噁唑烷衍生物、其制备方法和含这些化合物的药物制剂

Country Status (16)

Country Link
EP (1) EP0891359A1 (ko)
JP (1) JP2000510445A (ko)
KR (1) KR20000005117A (ko)
CN (1) CN1219933A (ko)
AR (1) AR006452A1 (ko)
AU (1) AU722747B2 (ko)
BR (1) BR9708475A (ko)
CA (1) CA2250250A1 (ko)
CZ (1) CZ305198A3 (ko)
HU (1) HUP9901741A3 (ko)
IL (1) IL126390A0 (ko)
NO (1) NO984547L (ko)
NZ (1) NZ332245A (ko)
PL (1) PL329053A1 (ko)
TR (1) TR199801961T2 (ko)
WO (1) WO1997036899A1 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2307899A (en) * 1997-12-23 1999-07-12 Alcon Laboratories, Inc. Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
WO2002074762A1 (fr) * 2001-03-15 2002-09-26 Takeda Chemical Industries, Ltd. Procede relatif a l'elaboration de derive sulfone
CN100352816C (zh) * 2001-04-18 2007-12-05 欧罗赛铁克股份有限公司 伤害感受肽类似物
AU2003235895A1 (en) * 2002-05-09 2003-11-11 Mochida Pharmaceutical Co., Ltd. Process for producing 1-(4-pyridyl)-4-piperidone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9122016D0 (en) * 1991-10-16 1991-11-27 Glaxo Group Ltd Chemical compounds
EP0542363A3 (en) * 1991-11-14 1993-07-14 Glaxo Group Limited Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
AU3351293A (en) * 1992-01-21 1993-08-03 Glaxo Group Limited Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
DK0623615T3 (da) * 1993-05-01 1999-12-13 Merck Patent Gmbh Adhæsionsreceptor-antagonister
DE19524765A1 (de) * 1995-07-07 1997-01-09 Boehringer Mannheim Gmbh Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
CA2250250A1 (en) 1997-10-09
BR9708475A (pt) 1999-04-13
IL126390A0 (en) 1999-05-09
HUP9901741A2 (hu) 1999-09-28
AR006452A1 (es) 1999-08-25
AU2505697A (en) 1997-10-22
NO984547L (no) 1998-11-30
NZ332245A (en) 2000-03-27
KR20000005117A (ko) 2000-01-25
WO1997036899A1 (de) 1997-10-09
HUP9901741A3 (en) 2000-03-28
EP0891359A1 (de) 1999-01-20
AU722747B2 (en) 2000-08-10
NO984547D0 (no) 1998-09-29
CZ305198A3 (cs) 1999-02-17
PL329053A1 (en) 1999-03-01
JP2000510445A (ja) 2000-08-15
TR199801961T2 (xx) 1999-01-18

Similar Documents

Publication Publication Date Title
CN1052231C (zh) 2－氧代－5－噁唑烷酮甲基化合物,它们的制备方法及含它们的药物组合物
CN1305839C (zh) 苯基甘氨酸衍生物
CN1164573C (zh) 新的α-氨基酸化合物、其制备方法和包含它们的药物组合物
CN1061654C (zh) 四唑衍生物的制备方法
CN1052227C (zh) 作为粘结受体拮抗剂的噁唑烷酮,其制备方法和含它们的药物组合物
CN1633297A (zh) 作为黑皮质素－4受体激动剂的酰化哌啶衍生物
CN1802376A (zh) Cgrp受体拮抗剂
CN1688544A (zh) 作为蕈毒碱受体拮抗剂的含氟代和磺酰氨基的3,6－二取代的氮杂双环(3.1.0)己烷衍生物
CN1228087A (zh) 取代的嘧啶衍生物和它们的药物用途
CN1468216A (zh) 含氮五员环化合物
CN1832742A (zh) 用于治疗心血管疾病的血管紧张素ii受体阻断剂氯沙坦、缬沙坦、坎地沙坦、替米沙坦、依普罗沙坦和奥美沙坦的硝基氧基衍生物
CN1845921A (zh) 金刚烷和氮杂双环－辛烷及壬烷衍生物、其制备方法及其作为dpp－iv抑制剂的用途
CN1018614B (zh) 制备含n-杂环基-4-哌啶胺类的抗组胺组合物的方法
CN1015054B (zh) N-吲哚基乙基-磺酰胺类的制备方法
CN1076928A (zh) 1-[2-芳磺酰基氨基)-1-氧代乙基]哌啶衍生物及其制备和在治疗上的应用
CN1030452C (zh) 2-氨基嘧啶酮衍生物的制备方法
CN1091742A (zh) 水溶性喜树碱衍生物
CN87103504A (zh) 杂环羧酰胺
CN1087741C (zh) 新型吲哚和吲唑化合物,其制备方法及含有它们的药物组合物
CN1069640C (zh) 噁唑烷酮衍生物,其制备方法及含它们的药物组合物
CN1025676C (zh) 非肽的血管紧张肽原酶抑制剂的制备
CN1029964C (zh) 新的n-(4-哌啶基)双环缩合2-咪唑胺衍生物的制备方法
CN1219933A (zh) 新的噁唑烷衍生物、其制备方法和含这些化合物的药物制剂
CN1155570C (zh) 新的氰基-吲哚5-羟色胺再摄取抑制剂化合物、其制备方法和含有它们的药物组合物
CN1297558C (zh) 新的4－氧代－4,6,7,8－四氢－吡咯并[1,2－a]吡嗪－6－甲酰胺化合物,其制备方法和包含它们的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1021369

Country of ref document: HK